Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based […]
Select Bancorp Reports Second Quarter 2020 Earnings
DUNN, N.C., Aug. 05, 2020 (GLOBE NEWSWIRE) — Select Bancorp, Inc. (NASDAQ: SLCT) (the “Company”), the holding company for Select […]
International Money Express Updates 2Q20 Earnings Presentation with Immaterial Revision
MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) has revised slide 5 of its second […]
21Vianet Announces Tim Chen as Chief Strategy Officer
BEIJING, Aug. 05, 2020 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14, 2020 Conference Call and Provide Business Update
SPARTA, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty […]
SMTC Corporation Announces Second Quarter Results
TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — SMTC Corporation (Nasdaq:SMTX), a global electronics manufacturing services provider and winners of Frost […]
Atreca to Present at Two Upcoming Virtual Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused […]
QIWI to Announce Second Quarter 2020 Financial Results on August 19, 2020
NICOSIA, Cyprus, Aug. 05, 2020 (GLOBE NEWSWIRE) — QIWI plc, (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced […]
Gladstone Investment Corporation Launches Public Offering of 6.00% Notes
MCLEAN, Va., Aug. 05, 2020 (GLOBE NEWSWIRE) — Gladstone Investment Corporation (Nasdaq: GAIN) (the “Company”) today announced that on May […]
Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology […]
